Insulin and type 1 diabetes: immune connections

被引:29
|
作者
Culina, Sloboda [1 ,2 ]
Brezar, Vedran [1 ,2 ]
Mallone, Roberto [1 ,2 ,3 ]
机构
[1] Hop St Vincent de Paul, INSERM, U986, DeAR Lab Avenir, F-75674 Paris 14, France
[2] Paris Descartes Univ, Fac Med, Paris, France
[3] Hop Hotel Dieu, AP HP, Serv Diabetol, Paris, France
关键词
BETA-CELL FUNCTION; ANTIBODY STANDARDIZATION PROGRAM; THYMIC EPITHELIAL-CELLS; ALTERED-PEPTIDE LIGAND; AUTOREACTIVE T-CELLS; ORAL INSULIN; NOD MICE; 1ST-DEGREE RELATIVES; GENE-EXPRESSION; DENDRITIC CELLS;
D O I
10.1530/EJE-12-0693
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Insulin is the hormone produced by pancreatic beta-cells, with a central role in carbohydrate and fat metabolism. Together with its precursors preproinsulin and proinsulin, insulin is also a key target antigen (Ag) of the autoimmune islet destruction leading to type 1 diabetes. Being recognized by both autoantibodies (aAbs) and autoreactive T cells, insulin plays a triggering role, at least in rodent models, in diabetes pathogenesis. It is expressed not only by beta-cells but also in the thymus, where it plays a major role in central tolerance mechanisms. We will summarize current knowledge concerning insulin, its role in beta-cell autoimmunity as initial target Ag, its recognition by aAbs and autoreactive T cells, and the detection of these immune responses to provide biomarkers for clinical trials employing insulin as an immune modulatory agent. European Journal of Endocrinology 168 R19-R31
引用
收藏
页码:R19 / R31
页数:13
相关论文
共 50 条
  • [21] Immune mechanisms in type 1 diabetes
    Wallberg, Maja
    Cooke, Anne
    TRENDS IN IMMUNOLOGY, 2013, 34 (12) : 583 - 591
  • [22] Immune Tolerance in Type 1 Diabetes
    Aly, Hanan H.
    Snell-Bergeon, Janet K.
    Homann, Dirk
    Gottlieb, Peter A.
    DIABETES, 2011, 60 : A669 - A669
  • [23] Immune Intervention in Type 1 Diabetes
    Nambam, Bimota
    Bratina, Natasa
    Chatz, Desmond
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : S184 - S189
  • [24] Immune Intervention in Type 1 Diabetes
    Nambam, Bimota
    Bratina, Natasa
    Schatz, Desmond
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : S179 - S184
  • [25] Immune regulation in type 1 diabetes
    Shimada, A
    Charlton, B
    Rohane, P
    TaylorEdwards, C
    Fathman, CG
    JOURNAL OF AUTOIMMUNITY, 1996, 9 (02) : 263 - 269
  • [26] Immune Intervention in Type 1 Diabetes
    Nambam, Bimota
    Bratina, Natasa
    Schatz, Desmond
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : S141 - S148
  • [27] Immune Intervention in Type 1 Diabetes
    Nambam, Bimota
    Bratina, Natasa
    Schatz, Desmond
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : S69 - S75
  • [28] Insulin Analogues Insulin Glargine and Insulin Glulisine in Type 1 Diabetes
    Schreiber, S. A.
    Fiesselmann, A.
    Bornstein, S. R.
    Landgraf, W.
    DIABETES STOFFWECHSEL UND HERZ, 2011, 20 (02): : 69 - 77
  • [29] Is type 1 diabetes a disease of the gut immune system triggered by cow's milk insulin?
    Vaarala, O
    EARLY NUTRITION AND ITS LATER CONSEQUENCES: NEW OPPORTUNITIES: PERINATAL PROGRAMMING OF ADULT HEALTH - EC SUPPORTED RESEARCH, 2005, 569 : 151 - 156
  • [30] IMMUNE INTERVENTION TRIAL IN NEWLY DIAGNOSED TYPE-1 (INSULIN-DEPENDENT) DIABETES
    GREULICH, B
    LANDER, T
    STANDL, E
    KOLB, H
    GERBITZ, KD
    KUSCHAK, D
    GRIES, FA
    DIABETOLOGIA, 1983, 25 (02) : 158 - 158